1. Home
  2. LEGN vs AGNC Comparison

LEGN vs AGNC Comparison

Compare LEGN & AGNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LEGN
  • AGNC
  • Stock Information
  • Founded
  • LEGN 2014
  • AGNC 2008
  • Country
  • LEGN United States
  • AGNC United States
  • Employees
  • LEGN N/A
  • AGNC N/A
  • Industry
  • LEGN Biotechnology: Pharmaceutical Preparations
  • AGNC Real Estate Investment Trusts
  • Sector
  • LEGN Health Care
  • AGNC Real Estate
  • Exchange
  • LEGN Nasdaq
  • AGNC Nasdaq
  • Market Cap
  • LEGN 5.4B
  • AGNC 9.2B
  • IPO Year
  • LEGN 2020
  • AGNC 2008
  • Fundamental
  • Price
  • LEGN $38.96
  • AGNC $9.40
  • Analyst Decision
  • LEGN Strong Buy
  • AGNC Buy
  • Analyst Count
  • LEGN 12
  • AGNC 11
  • Target Price
  • LEGN $73.91
  • AGNC $9.79
  • AVG Volume (30 Days)
  • LEGN 1.6M
  • AGNC 22.3M
  • Earning Date
  • LEGN 08-08-2025
  • AGNC 07-21-2025
  • Dividend Yield
  • LEGN N/A
  • AGNC 15.24%
  • EPS Growth
  • LEGN N/A
  • AGNC N/A
  • EPS
  • LEGN N/A
  • AGNC 0.40
  • Revenue
  • LEGN $728,303,000.00
  • AGNC $584,000,000.00
  • Revenue This Year
  • LEGN $65.49
  • AGNC $39.36
  • Revenue Next Year
  • LEGN $53.76
  • AGNC $22.20
  • P/E Ratio
  • LEGN N/A
  • AGNC $23.66
  • Revenue Growth
  • LEGN 112.46
  • AGNC N/A
  • 52 Week Low
  • LEGN $27.34
  • AGNC $7.85
  • 52 Week High
  • LEGN $60.87
  • AGNC $10.85
  • Technical
  • Relative Strength Index (RSI)
  • LEGN 66.26
  • AGNC 56.15
  • Support Level
  • LEGN $34.64
  • AGNC $9.33
  • Resistance Level
  • LEGN $39.88
  • AGNC $9.54
  • Average True Range (ATR)
  • LEGN 1.46
  • AGNC 0.14
  • MACD
  • LEGN 0.37
  • AGNC 0.00
  • Stochastic Oscillator
  • LEGN 87.67
  • AGNC 71.43

About LEGN Legend Biotech Corporation

Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.

About AGNC AGNC Investment Corp.

AGNC Investment Corp is a real estate investment trust that invests in agency residential mortgage-backed securities. The firm's asset portfolio is comprised of residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by a U.S. Government-sponsored enterprise, such as the Federal National Mortgage Association and the Federal Home Loan Mortgage Corporation, or by a U.S. Government agency, such as the Government National Mortgage Association. It also invests in other types of mortgage and mortgage-related residential and commercial mortgage-backed securities or other investments in or related to, the housing, mortgage, or real estate markets.

Share on Social Networks: